Moyle GJ - Search Results

1

Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission.

Vithayasai V, Moyle GJ, Supajatura V, Wattanatchariya N, Kanshana S, Sirichthaporn P, Dabtham K, Somburanasin P, Chantawuttinan T, Hill AM, Hawkins D. Vithayasai V, et al. Among authors: moyle gj. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):410-2. doi: 10.1097/00042560-200208010-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12138347 Clinical Trial.

2

Seminoma and HIV infections.

Moyle G, Hawkins DA, Gazzard BG. Moyle G, et al. Int J STD AIDS. 1991 Jul-Aug;2(4):293-4. doi: 10.1177/095646249100200416. Int J STD AIDS. 1991. PMID: 1911965 No abstract available.

3

The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT).

Moyle GJ, Nelson MR, Hawkins D, Gazzard BG. Moyle GJ, et al. Q J Med. 1993 Mar;86(3):155-63. Q J Med. 1993. PMID: 8387218

4

Lipid abnormalities during saquinavir soft-gel-based highly active antiretroviral therapy.

Moyle GJ, Baldwin C. Moyle GJ, et al. J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):423-4. J Acquir Immune Defic Syndr. 1999. PMID: 10458625 No abstract available.

5

The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues. Study of Protease Inhibitor Combinations in Europe.

Moyle G, Pozniak A, Opravil M, Clumeck N, DelFraissy JF, Johnson M, Pelgrom J, Reynes J, Vittecoq D, DeLora P, Salgo M, Duff F. Moyle G, et al. J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):128-37. doi: 10.1097/00126334-200002010-00004. J Acquir Immune Defic Syndr. 2000. PMID: 10737427 Clinical Trial.

6

Interaction between saquinavir soft-gel and rifabutin in patients infected with HIV.

Moyle GJ, Buss NE, Goggin T, Snell P, Higgs C, Hawkins DA. Moyle GJ, et al. Br J Clin Pharmacol. 2002 Aug;54(2):178-82. doi: 10.1046/j.1365-2125.2002.01631.x. Br J Clin Pharmacol. 2002. PMID: 12207638 Free PMC article. Clinical Trial.

7

Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies.

Moyle G, Sawyer W, Law M, Amin J, Hill A. Moyle G, et al. Clin Ther. 2004 Jan;26(1):92-7. doi: 10.1016/s0149-2918(04)90009-4. Clin Ther. 2004. PMID: 14996521

8

Intracellular and plasma pharmacokinetics of saquinavir-ritonavir, administered at 1,600/100 milligrams once daily in human immunodeficiency virus-infected patients.

Ford J, Boffito M, Wildfire A, Hill A, Back D, Khoo S, Nelson M, Moyle G, Gazzard B, Pozniak A. Ford J, et al. Antimicrob Agents Chemother. 2004 Jul;48(7):2388-93. doi: 10.1128/AAC.48.7.2388-2393.2004. Antimicrob Agents Chemother. 2004. PMID: 15215085 Free PMC article. Clinical Trial.

9

Pharmacokinetics of once-daily saquinavir/ritonavir in HIV-infected subjects: comparison with the standard twice-daily regimen.

Boffito M, Dickinson L, Hill A, Back D, Moyle G, Nelson M, Higgs C, Fletcher C, Mandalia S, Gazzard B, Pozniak A. Boffito M, et al. Antivir Ther. 2004 Jun;9(3):423-9. Antivir Ther. 2004. PMID: 15259905 Clinical Trial.

10

Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen.

Boffito M, Kurowski M, Kruse G, Hill A, Benzie AA, Nelson MR, Moyle GJ, Gazzard BG, Pozniak AL. Boffito M, et al. Among authors: moyle gj. AIDS. 2004 Jun 18;18(9):1291-7. doi: 10.1097/00002030-200406180-00007. AIDS. 2004. PMID: 15362661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters